NEW YORK (GenomeWeb News) – Monsanto has acquired agricultural biotechnology firm GrassRoots Biotechnology for an undisclosed amount.

The acquisition was made earlier this month, and in an e-mail to GenomeWeb Daily News, a Monsanto spokesperson said, "GrassRoots focuses on gene expression and other agricultural technologies that will complement Monsanto's biotechnology research and development work."

All research employees will be offered positions at Monsanto. The spokesperson declined to disclose further terms of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.